CAeditome Logo

Home

Download

Statistics

Landscape

Help

Contact
Center for Computational Systems Medicine
Soverview

1. Gene summary of enriched editing regions

Soverview

2. Tumor-specific enriched editing regions

Comparison of enriched editing regions between tumor and normal.

Correlation of enriched editing regions with tumor stages.

Associations of enriched editing regions with cancer survival.

Soverview

3. Enriched editing regions and immune related genes

Soverview

4. Enriched editing regions and immune related splicing

Soverview

5. Enriched editing regions and immune infiltration

Soverview

6. Enriched editing regions and immune gene sets

Correlation of enriched editing regions with epithelial-mesenchymal transition.

Correlations of enriched editing regions with hypoxic.

Associations of enriched editing regions with hallmark gene sets from MSigDB.

Soverview

7. Enriched editing regions and drugs

Correlations between enriched editing regions and drug sensitivity.

Enriched editing regions targeted by drugs from DrugBank database.

Editing gene: CHST12 (ImmuneEditome ID:55501)

1. Gene summary of enriched editing regions for CHST12

check button Gene summary
Gene informationGene symbol

CHST12

Gene ID

55501

GeneSynonymsC4S-2|C4ST-2|C4ST2
GeneCytomap

7p22.3

GeneTypeprotein-coding
GeneDescriptioncarbohydrate sulfotransferase 12|carbohydrate (chondroitin 4) sulfotransferase 12|chondroitin 4-O-sulfotransferase 2|chondroitin 4-sulfotransferase 2|sulfotransferase Hlo
GeneModificationdate20230517
UniprotIDA0A024R860;Q9NRB3;C9J991
PubMed ID

check buttonUCSC image.
all structure

check buttonLocations of each EERs.
EERENSTENSGGeneNameRegionRepeatdsRNA structure
chr7:2434447-2436084:+ENST00000258711.7ENSG00000136213.9CHST12UTR3AluJb,(TAGA)n,AluJo,AluSzchr7:2434447-2436084:+.alignment
chr7:2434447-2436084:+ENST00000618655.1ENSG00000136213.9CHST12UTR3AluJb,(TAGA)n,AluJo,AluSzchr7:2434447-2436084:+.alignment
chr7:2441533-2442594:+ENST00000313156.3ENSG00000136213.9CHST12ncRNA_intronicL1MB3,AluJb,AluYchr7:2441533-2442594:+.alignment
chr7:2443916-2444394:+ENST00000313156.3ENSG00000136213.9CHST12ncRNA_intronicAluSx1,AluYa5chr7:2443916-2444394:+.alignment
chr7:2445433-2445726:+ENST00000313156.3ENSG00000136213.9CHST12ncRNA_intronicAluSx3chr7:2445433-2445726:+.alignment
chr7:2447524-2448185:+ENST00000313156.3ENSG00000136213.9CHST12ncRNA_exonicAluSz6,AluSz,MER41Bchr7:2447524-2448185:+.alignment


Top

2. Tumor-specific enriched editing regions for CHST12


all structure

check buttonComparison of enriched editing regions between tumor and normal.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
ID_eventscancerTypePBoxplot


Top

check buttonCorrelation of enriched editing regions with tumor stages.
* AnovaP<0.05, Pearson P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes, Path: Pathological stage, Cli: Clinical stage.
* Only shows the most significant correlation result of EERs/EAGs with either pathological stage or clinical stage according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeStageTypeAnovaPPRBoxplot
chr7:2447524-2448185:+KIRPCliEER1.6452e-042.0887e-050.5122image
ENSG00000136213.9,CHST12KIRPCliEAG5.5413e-031.1511e-030.3033image
chr7:2434447-2436084:+KIRPCliEER9.9804e-031.0009e-020.2604image


Top

check button Associations of enriched editing regions with cancer survival.
* Pkm<0.05 and Pcox<0.05.
* EER: enriched editing region, EAG: EER-associated genes.
ID_eventscancerTypeIDPkmPcox_continuousHR_continuousKMPlot
chr7:2441533-2442594:+STADEER1.9722e-032.1995e-023.3301e-04image

Top

3. Enriched editing regions and immune related genes for CHST12


all structure

check button Enriched editing regions and immune related genes.
* First, the associations between enriched editing regions and genes were tested by QTL and Pearson method (QTL: FDR<0.05 and Pearson: P<0.05).
* Second, the gene relationships with immune were tested by three analyses: whether the gene is an immune gene (InnateDB、Immport、Immunome、Immunogenetic Related Information Source (IRIS)), whether the gene is associated with immune infiltration and whether the gene is related to immune gene sets.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of genes with the fraction of different immune cells and the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeGenebetaFDRPearsonPPearsonRCorrelationPlotRBPRBPtargetsImmuneGeneImmuneFractionHallMark
chr7:2434447-2436084:+PCPGEERENSG00000135766,EGLN10.43341.2726e-043.5958e-070.4287imageNNNAMast_cells_activatedGSVA_HALLMARK_MITOTIC_SPINDLE
chr7:2434447-2436084:+PCPGEERENSG00000204138,PHACTR40.42382.0941e-041.1742e-070.4445imageNNNAMast_cells_restingGSVA_HALLMARK_TGF_BETA_SIGNALING
chr7:2434447-2436084:+PCPGEERENSG00000189266,PNRC20.41763.2050e-045.6037e-070.4223imageNNNAT_cells_regulatory_(Tregs)GSVA_HALLMARK_TGF_BETA_SIGNALING
chr7:2434447-2436084:+PCPGEERENSG00000011007,TCEB30.39707.7875e-041.4985e-060.4075imageNNNAEosinophilsGSVA_HALLMARK_G2M_CHECKPOINT
chr7:2434447-2436084:+PCPGEERENSG00000172493,AFF10.38901.0173e-031.7345e-060.4052imageNNAFF1T_cells_regulatory_(Tregs)GSVA_HALLMARK_MITOTIC_SPINDLE
chr7:2434447-2436084:+PCPGEERENSG00000108100,CCNY0.36612.2625e-031.9880e-060.4031imageNNNAMast_cells_restingGSVA_HALLMARK_TGF_BETA_SIGNALING
chr7:2434447-2436084:+PCPGEERENSG00000125945,ZNF4360.35503.0697e-034.5561e-070.4253imageNNNAMast_cells_restingGSVA_HALLMARK_MITOTIC_SPINDLE
chr7:2434447-2436084:+PCPGEERENSG00000117713,ARID1A0.36003.1828e-031.0313e-060.4132imageNNNAMast_cells_restingGSVA_HALLMARK_MITOTIC_SPINDLE
chr7:2434447-2436084:+PCPGEERENSG00000197312,DDI20.33307.5428e-032.0296e-060.4028imageNNNANK_cells_activatedGSVA_HALLMARK_TGF_BETA_SIGNALING
chr7:2434447-2436084:+PCPGEERENSG00000135766,EGLN10.43341.2726e-043.5958e-070.4287imageNNNAMast_cells_activatedGSVA_HALLMARK_MITOTIC_SPINDLE
chr7:2434447-2436084:+PCPGEERENSG00000204138,PHACTR40.42382.0941e-041.1742e-070.4445imageNNNAMast_cells_restingGSVA_HALLMARK_TGF_BETA_SIGNALING
chr7:2434447-2436084:+PCPGEERENSG00000189266,PNRC20.41763.2050e-045.6037e-070.4223imageNNNAT_cells_regulatory_(Tregs)GSVA_HALLMARK_TGF_BETA_SIGNALING
chr7:2434447-2436084:+PCPGEERENSG00000011007,TCEB30.39707.7875e-041.4985e-060.4075imageNNNAEosinophilsGSVA_HALLMARK_G2M_CHECKPOINT
chr7:2434447-2436084:+PCPGEERENSG00000172493,AFF10.38901.0173e-031.7345e-060.4052imageNNAFF1T_cells_regulatory_(Tregs)GSVA_HALLMARK_MITOTIC_SPINDLE
chr7:2434447-2436084:+PCPGEERENSG00000108100,CCNY0.36612.2625e-031.9880e-060.4031imageNNNAMast_cells_restingGSVA_HALLMARK_TGF_BETA_SIGNALING
chr7:2434447-2436084:+PCPGEERENSG00000125945,ZNF4360.35503.0697e-034.5561e-070.4253imageNNNAMast_cells_restingGSVA_HALLMARK_MITOTIC_SPINDLE
chr7:2434447-2436084:+PCPGEERENSG00000117713,ARID1A0.36003.1828e-031.0313e-060.4132imageNNNAMast_cells_restingGSVA_HALLMARK_MITOTIC_SPINDLE
chr7:2434447-2436084:+PCPGEERENSG00000197312,DDI20.33307.5428e-032.0296e-060.4028imageNNNANK_cells_activatedGSVA_HALLMARK_TGF_BETA_SIGNALING

More results



Top

4. Enriched editing regions and immune related splicing for CHST12


all structure

check button Enriched editing regions and immune related splicing.
* First, the associations between enriched editing regions and splicing events were tested by QTL and Pearson method (QTL: FDR<0.05 and Pearson: P<0.05).
* Second, the splicing relationships with immune were tested by three analyses: whether the splicing event locates in an immune gene (InnateDB、Immport, Immunome and Immunogenetic Related Information Source (IRIS)), whether the splicing event is associated with immune infiltration and whether the splicing event is related to immune gene sets.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of splicing events with the fraction of different immune cells and the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeSplicingTypeSplicingGeneSplicingChrSplicingPositionbetaFDRPearsonPPearsonRCorrelationPlotRBPRBPtargetsImmuneGeneImmuneFractionHallMark

More results



Top

5. Enriched editing regions and immune infiltration for CHST12


all structure

check button Associations of enriched editing regions with immune infiltration.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the fraction of different immune cells according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeIDImmuneCellPRCorrelationPlot
chr7:2434447-2436084:+BLCAEERMacrophages_M27.8289e-030.2953image
chr7:2447524-2448185:+BLCAEERMacrophages_M21.1193e-020.3669image
ENSG00000136213.9,CHST12BLCAEAGMacrophages_M26.5951e-050.3846image
chr7:2434447-2436084:+BRCAEERDendritic_cells_resting2.2400e-030.1631image
ENSG00000136213.9,CHST12BRCAEAGDendritic_cells_resting2.2492e-020.1186image
chr7:2434447-2436084:+CESCEERPlasma_cells1.9410e-02-0.3990image
ENSG00000136213.9,CHST12CESCEAGPlasma_cells1.7764e-02-0.3826image
chr7:2434447-2436084:+ESCAEERT_cells_gamma_delta1.9596e-040.3890image
ENSG00000136213.9,CHST12ESCAEAGT_cells_gamma_delta2.4451e-040.3590image
ENSG00000136213.9,CHST12HNSCEAGNeutrophils7.0584e-03-0.3215image
ENSG00000136213.9,CHST12KICHEAGEosinophils3.7052e-020.4469image
chr7:2434447-2436084:+KIRCEERMacrophages_M01.4809e-020.1562image
chr7:2447524-2448185:+KIRCEERB_cells_naive1.3952e-030.4939image
ENSG00000136213.9,CHST12KIRCEAGMacrophages_M02.6267e-020.1403image
chr7:2447524-2448185:+KIRPEERB_cells_naive8.2020e-040.3503image
ENSG00000136213.9,CHST12KIRPEAGMacrophages_M13.5889e-020.1671image
chr7:2434447-2436084:+LAMLEERMast_cells_activated1.5628e-030.3287image
ENSG00000136213.9,CHST12LAMLEAGNK_cells_activated8.5950e-030.2409image
chr7:2434447-2436084:+LGGEERMacrophages_M01.6249e-040.2288image
ENSG00000136213.9,CHST12LGGEAGMacrophages_M02.7193e-030.1808image
ENSG00000136213.9,CHST12LIHCEAGMast_cells_resting9.1470e-03-0.5203image
chr7:2447524-2448185:+LUADEERT_cells_CD82.3146e-020.2237image
chr7:2434447-2436084:+OVEERT_cells_CD4_memory_resting4.1377e-020.2143image
chr7:2434447-2436084:+PCPGEERNK_cells_activated2.6426e-02-0.1947image
chr7:2447524-2448185:+PCPGEEREosinophils9.7724e-030.3159image
ENSG00000136213.9,CHST12PCPGEAGEosinophils2.6344e-020.1912image
chr7:2434447-2436084:+PRADEERNK_cells_resting5.4635e-040.2663image
ENSG00000136213.9,CHST12PRADEAGT_cells_CD4_memory_activated4.4658e-040.2516image
chr7:2447524-2448185:+SARCEERMonocytes2.6813e-020.4258image
ENSG00000136213.9,CHST12SKCMEAGMacrophages_M12.7728e-02-0.1961image
chr7:2434447-2436084:+STADEERDendritic_cells_activated1.8314e-020.1829image
chr7:2447524-2448185:+STADEERT_cells_regulatory_(Tregs)4.3386e-02-0.1976image
ENSG00000136213.9,CHST12STADEAGT_cells_regulatory_(Tregs)4.1629e-02-0.1453image
ENSG00000136213.9,CHST12TGCTEAGT_cells_CD4_memory_resting1.7252e-020.2451image
chr7:2434447-2436084:+THCAEERT_cells_CD4_memory_activated6.7446e-040.3125image
chr7:2447524-2448185:+THCAEERMacrophages_M02.3896e-020.3707image
ENSG00000136213.9,CHST12THCAEAGT_cells_CD81.1294e-02-0.2242image
chr7:2434447-2436084:+THYMEERT_cells_follicular_helper3.7111e-02-0.3487image
chr7:2447524-2448185:+THYMEERT_cells_gamma_delta8.6069e-030.4954image
ENSG00000136213.9,CHST12THYMEAGT_cells_gamma_delta2.6252e-020.3207image
chr7:2434447-2436084:+UCECEERNeutrophils5.5556e-030.4862image
ENSG00000136213.9,CHST12UCECEAGMacrophages_M02.9720e-02-0.3358image


Top

6. Enriched editing regions and immune gene sets for CHST12


all structure

check button Correlation of enriched editing regions with epithelial-mesenchymal transition.
* First, the differences of enriched editing regions between Epi and Mes groups (defined by KS-test) were compared (P<0.05 and Informative number >=20).
* Second, the correlations between enriched editing regions and gene set score of HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the EERs/EAGs significantly edited between Epi and Mes group.
ID_eventscancerTypeE2M_PBoxplotCorPCorRCorrelationPlot


Top

check button Correlations of enriched editing regions with hypoxic.
* First, there are four hypoxia scores used in the database. The first three hypoxic scores were calculated on three gene sets of Buffa, Ragnum and Winter based on one previous study (PMID: 32024819). One last hypoxia score was defined on HALLMARK_HYPOXIA by GSVA method.
* Second, the correlations enriched editing regions with the four hypoxic scores were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the EERs/EAGs significantly correlated with all four hypoxia gene set scores. For more results, please go to download page.
ID_eventscancerTypeBuffa_P Buffa_R Ragnum_P Ragnum_R Winter_P Winter_R HALLMARK_P HALLMARK_R CorrelationPlot
chr7:2447524-2448185:+BLCAEER4.7402e-030.40504.6541e-020.29181.5857e-030.44816.1302e-030.3941image
chr7:2434447-2436084:+PCPGEER5.4128e-030.24261.1648e-020.22064.7318e-040.30231.7075e-020.2089image


Top

check button Associations of enriched editing regions with hallmark gene sets from MSigDB.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerHallmarkTypeTypePRCorrelationPlot
chr7:2434447-2436084:+BLCAGSVA_HALLMARK_GLYCOLYSISEER4.9559e-030.3112image
chr7:2447524-2448185:+BLCAGSVA_HALLMARK_GLYCOLYSISEER8.4403e-040.4706image
chr7:2447524-2448185:+BRCAGSVA_HALLMARK_PANCREAS_BETA_CELLSEER4.1925e-020.2059image
chr7:2434447-2436084:+BRCAGSVA_HALLMARK_PROTEIN_SECRETIONEER9.6145e-040.1760image
ENSG00000136213.9,CHST12BRCAGSVA_HALLMARK_ANDROGEN_RESPONSEEAG6.2836e-030.1418image
chr7:2447524-2448185:+ESCAGSVA_HALLMARK_CHOLESTEROL_HOMEOSTASISEER2.0930e-020.3325image
ENSG00000136213.9,CHST12GBMGSVA_HALLMARK_APICAL_SURFACEEAG1.4786e-030.3781image
ENSG00000136213.9,CHST12HNSCGSVA_HALLMARK_TGF_BETA_SIGNALINGEAG4.1221e-020.2464image
ENSG00000136213.9,CHST12KICHGSVA_HALLMARK_MYC_TARGETS_V2EAG4.7010e-02-0.4278image
ENSG00000136213.9,CHST12KIRCGSVA_HALLMARK_GLYCOLYSISEAG2.6028e-040.2286image
chr7:2434447-2436084:+KIRCGSVA_HALLMARK_GLYCOLYSISEER1.0524e-040.2462image
chr7:2447524-2448185:+KIRCGSVA_HALLMARK_UV_RESPONSE_DNEER1.0498e-020.4052image
chr7:2447524-2448185:+KIRPGSVA_HALLMARK_PROTEIN_SECRETIONEER4.2659e-020.2166image
chr7:2434447-2436084:+KIRPGSVA_HALLMARK_MTORC1_SIGNALINGEER8.9959e-040.2815image
ENSG00000136213.9,CHST12KIRPGSVA_HALLMARK_PANCREAS_BETA_CELLSEAG5.2341e-030.2211image
ENSG00000136213.9,CHST12LAMLGSVA_HALLMARK_KRAS_SIGNALING_DNEAG1.4934e-030.2892image
ENSG00000136213.9,CHST12LGGGSVA_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITIONEAG2.0730e-020.1399image
chr7:2434447-2436084:+LGGGSVA_HALLMARK_ANDROGEN_RESPONSEEER1.9102e-020.1434image
chr7:2447524-2448185:+LUADGSVA_HALLMARK_IL6_JAK_STAT3_SIGNALINGEER2.4449e-050.4029image
ENSG00000136213.9,CHST12LUADGSVA_HALLMARK_PEROXISOMEEAG2.1265e-03-0.2124image
ENSG00000136213.9,CHST12OVGSVA_HALLMARK_CHOLESTEROL_HOMEOSTASISEAG1.0560e-020.2317image
chr7:2434447-2436084:+OVGSVA_HALLMARK_ADIPOGENESISEER1.0413e-030.3382image
chr7:2447524-2448185:+OVGSVA_HALLMARK_E2F_TARGETSEER4.0271e-02-0.2532image
ENSG00000136213.9,CHST12PCPGGSVA_HALLMARK_PI3K_AKT_MTOR_SIGNALINGEAG5.6779e-030.2368image
chr7:2447524-2448185:+PCPGGSVA_HALLMARK_KRAS_SIGNALING_UPEER3.8502e-020.2554image
chr7:2434447-2436084:+PCPGGSVA_HALLMARK_PI3K_AKT_MTOR_SIGNALINGEER5.9961e-040.2970image
chr7:2447524-2448185:+PRADGSVA_HALLMARK_PROTEIN_SECRETIONEER2.3587e-020.2595image
chr7:2434447-2436084:+PRADGSVA_HALLMARK_MYC_TARGETS_V1EER6.4149e-060.3432image
ENSG00000136213.9,CHST12PRADGSVA_HALLMARK_MYC_TARGETS_V1EAG3.0640e-060.3303image
chr7:2434447-2436084:+SARCGSVA_HALLMARK_ANDROGEN_RESPONSEEER1.1656e-020.3042image
chr7:2447524-2448185:+SKCMGSVA_HALLMARK_DNA_REPAIREER3.6463e-02-0.3549image
chr7:2434447-2436084:+STADGSVA_HALLMARK_NOTCH_SIGNALINGEER3.5573e-040.2739image
chr7:2447524-2448185:+STADGSVA_HALLMARK_P53_PATHWAYEER5.2089e-040.3329image
ENSG00000136213.9,CHST12STADGSVA_HALLMARK_TNFA_SIGNALING_VIA_NFKBEAG1.3996e-030.2261image
ENSG00000136213.9,CHST12TGCTGSVA_HALLMARK_MITOTIC_SPINDLEEAG7.8386e-050.3959image
chr7:2445433-2445726:+TGCTGSVA_HALLMARK_WNT_BETA_CATENIN_SIGNALINGEER1.1803e-03-0.5003image
ENSG00000136213.9,CHST12THCAGSVA_HALLMARK_INTERFERON_GAMMA_RESPONSEEAG2.9718e-040.3159image
chr7:2447524-2448185:+THCAGSVA_HALLMARK_COAGULATIONEER2.7945e-020.3614image
chr7:2434447-2436084:+THCAGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER4.8241e-040.3204image
chr7:2447524-2448185:+THYMGSVA_HALLMARK_MTORC1_SIGNALINGEER2.7552e-040.6457image
chr7:2434447-2436084:+THYMGSVA_HALLMARK_UV_RESPONSE_DNEER4.2478e-030.4652image
chr7:2434447-2436084:+UCECGSVA_HALLMARK_PEROXISOMEEER1.5629e-030.5439image
ENSG00000136213.9,CHST12UCECGSVA_HALLMARK_BILE_ACID_METABOLISMEAG4.0133e-040.5212image


Top

7. Enriched editing regions and drugs for CHST12


all structure

check button Correlations between enriched editing regions and drug sensitivity.
* First, the drug sensitivity (IS50) was estimated on 84 drugs by pRRophetic package.
* Second, the correlations between editing enriched regions and drug sensitivity were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the IS50 scores of 84 drugs according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerDrugTypePRCorrelationPlot
chr7:2447524-2448185:+BLCAGW.441756EER2.2267e-030.4353image
ENSG00000136213.9,CHST12BLCAFTI.277EAG5.4017e-03-0.2736image
chr7:2434447-2436084:+BLCAGNF.2EER1.2030e-03-0.3557image
chr7:2434447-2436084:+BRCAAKT.inhibitor.VIIIEER3.0687e-04-0.1921image
chr7:2447524-2448185:+BRCALFM.A13EER2.0103e-02-0.2345image
ENSG00000136213.9,CHST12BRCAAKT.inhibitor.VIIIEAG3.2243e-03-0.1528image
ENSG00000136213.9,CHST12CESCEHT.1864EAG1.6115e-020.3879image
chr7:2434447-2436084:+CESCEHT.1864EER2.9768e-020.3731image
ENSG00000136213.9,CHST12ESCAEHT.1864EAG2.1401e-020.2299image
chr7:2434447-2436084:+ESCAEHT.1864EER2.5170e-020.2400image
chr7:2447524-2448185:+ESCAA.770041EER1.4345e-02-0.3513image
ENSG00000136213.9,CHST12GBMCamptothecinEAG3.1357e-030.3532image
ENSG00000136213.9,CHST12KIRCGW.441756EAG5.0081e-03-0.1766image
chr7:2434447-2436084:+KIRCGW.441756EER1.4078e-03-0.2037image
chr7:2447524-2448185:+KIRCDMOGEER7.5088e-04-0.5170image
chr7:2447524-2448185:+KIRPAMG.706EER1.4895e-040.3935image
chr7:2434447-2436084:+KIRPCCT018159EER3.9271e-030.2458image
ENSG00000136213.9,CHST12KIRPAZD6244EAG1.4916e-030.2506image
ENSG00000136213.9,CHST12LAMLATRAEAG1.6688e-030.2864image
chr7:2434447-2436084:+LAMLEmbelinEER2.5129e-030.3148image
ENSG00000136213.9,CHST12LGGBicalutamideEAG5.7224e-03-0.1668image
chr7:2434447-2436084:+LGGBicalutamideEER7.0338e-03-0.1646image
ENSG00000136213.9,CHST12LIHCJW.7.52.1EAG3.6888e-02-0.4281image
chr7:2447524-2448185:+LUADGW.441756EER2.7311e-040.3514image
ENSG00000136213.9,CHST12LUADAP.24534EAG3.5945e-02-0.1459image
ENSG00000136213.9,CHST12OVGSK269962AEAG2.1961e-020.2082image
chr7:2447524-2448185:+OVBI.D1870EER4.5213e-020.2474image
chr7:2434447-2436084:+OVGSK269962AEER4.7178e-030.2937image
ENSG00000136213.9,CHST12PAADBMS.754807EAG1.8505e-03-0.5811image
ENSG00000136213.9,CHST12PCPGBAY.61.3606EAG1.0538e-02-0.2195image
chr7:2434447-2436084:+PCPGBAY.61.3606EER5.5701e-03-0.2418image
chr7:2447524-2448185:+PCPGAZD8055EER2.2424e-040.4393image
chr7:2434447-2436084:+PRADCCT018159EER4.9556e-030.2178image
ENSG00000136213.9,CHST12PRADBryostatin.1EAG2.6713e-030.2162image
chr7:2447524-2448185:+PRADBMS.708163EER1.0995e-02-0.2902image
ENSG00000136213.9,CHST12SARCEtoposideEAG2.8500e-02-0.2391image
chr7:2434447-2436084:+SARCCMKEER1.2205e-020.3024image
chr7:2447524-2448185:+SARCBMS.754807EER1.6528e-02-0.4571image
chr7:2447524-2448185:+SKCMBIBW2992EER4.5082e-05-0.6329image
ENSG00000136213.9,CHST12SKCMBIBW2992EAG8.6542e-05-0.3425image
ENSG00000136213.9,CHST12STADAZD6244EAG2.6721e-02-0.1579image
chr7:2441533-2442594:+STADBIRB.0796EER8.4296e-030.4446image
chr7:2434447-2436084:+STADAZD6244EER3.5075e-02-0.1637image
chr7:2447524-2448185:+STADABT.263EER5.9396e-040.3297image
ENSG00000136213.9,CHST12TGCTBryostatin.1EAG7.6642e-040.3411image
chr7:2447524-2448185:+TGCTElesclomolEER4.5089e-02-0.2642image
chr7:2445433-2445726:+TGCTMetforminEER1.1566e-030.5011image
chr7:2434447-2436084:+THCACI.1040EER7.0457e-04-0.3114image
chr7:2447524-2448185:+THCACGP.082996EER1.7851e-03-0.4963image
ENSG00000136213.9,CHST12THCAAG.014699EAG1.1544e-030.2852image
chr7:2434447-2436084:+THYMDocetaxelEER2.0200e-020.3856image
ENSG00000136213.9,CHST12THYMDMOGEAG1.6515e-02-0.3444image
chr7:2447524-2448185:+THYMCGP.082996EER4.0616e-03-0.5347image
ENSG00000136213.9,CHST12UCECBMS.708163EAG2.6010e-02-0.3433image
chr7:2434447-2436084:+UCECMetforminEER4.6574e-03-0.4948image


Top

check button EAGs targeted by drugs from DrugBank database.
* EAG: EER-associated genes.
EERENSTUniprotIDDrugBankIDDrugDrugType